Skip to main content

G 369 (Topiramate Extended-Release 100 mg)

Pill with imprint G 369 is Orange / Gray, Capsule-shape and has been identified as Topiramate Extended-Release 100 mg. It is supplied by Glenmark Pharmaceuticals Inc.

Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizures; seizure prevention; migraine prevention and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 369

Topiramate Extended-Release

G 369
100 mg
Orange / Gray
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Glenmark Pharmaceuticals Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Related Images for "G 369"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.